Clinical efficacy and safety of interferon (Type I and Type III) therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials

Interferon (IFN) has been highlighted in several randomized controlled trials as an attractive therapeutic candidate based plausible mode of action, suppressed response in severe COVID-19, and inhibition of SARS-CoV-2 replication. This study investigated the efficacy and safety of IFN in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryoo, Seungeun, Koh, Dae-Hyup, Yu, Su-Yeon, Choi, Miyoung, Huh, Kyungmin, Yeom, Joon-Sup, Heo, Jung Yeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057835/
https://www.ncbi.nlm.nih.gov/pubmed/36989209
http://dx.doi.org/10.1371/journal.pone.0272826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057835/
https://www.ncbi.nlm.nih.gov/pubmed/36989209
http://dx.doi.org/10.1371/journal.pone.0272826

Ejemplares similares